Literature DB >> 7576048

What is the MHC?

S H Powis1, D E Geraghty.   

Abstract

Mesh：

Year:  1995        PMID： 7576048     DOI： 10.1016/0167-5699(95)80028-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  3 in total

1.  Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.

Authors:  Erik Evensen; Diane Joseph-McCarthy; Gregory A Weiss; Stuart L Schreiber; Martin Karplus
Journal:  J Comput Aided Mol Des       Date:  2007-07-27       Impact factor: 3.686

Review 2.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

3.  HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID).

Authors:  E G De La Concha; M Fernandez-Arquero; A Martinez; F Vidal; P Vigil; L Conejero; M C Garcia-Rodriguez; G Fontan
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.